Therefore, we can hypothesize that p53-dependent signals might be responsible for the systemic anti-tumor effect of RT, and an evaluation of the status of p53 in vivo might be used to predict the possibility of the occurrence of abscopal effects for cancer patients treated with RT regimens and thus provide better treatment administration. Here, TP53 is linked to cancer.